(Press-News.org) Reston, VA—A novel PET imaging tracer has been proven to safely and effectively detect a common cancer gene mutation that is an important molecular marker for tumor-targeted therapy. By identifying this mutation early, physicians can tailor treatment plans for patients to achieve the best results. This research was published in the December issue of The Journal of Nuclear Medicine.
Kirsten rat sarcoma (KRAS) is a commonly mutated oncogene that is present in approximately 20-70 percent of cancer cases. Patients with KRAS mutations usually respond poorly to standard therapies. As such, the National Comprehensive Cancer Network and other leading cancer research centers recommend assessing the mutation status in cancer patients to determine the most effective treatment.
“Currently, KRAS mutation screening relies on a biopsy combined with gene sequencing. However, biopsies have the potential for significant complications and their use is limited by the quality of the tissue sample. Thus, there is an urgent need for accurate yet noninvasive methods of evaluating the KRAS mutation status,” stated Jing Wang, MD, PhD, nuclear medicine physician at Xijing Hospital of Fourth Military Medical University in Xi’an, China.
In this first-in-humans study, researchers sought to develop a KRAS-targeted radiotracer and investigate its targeting potential in non-small cell lung cancer (NSCLC) and colorectal cancer.
An oncoprotein-targeted PET tracer, 18F-PFPMD, was created based on a recently FDA-approved KRASG12C inhibitor. The targeting specificity and imaging ability of the tracer were assessed through both in vitro and in vivo study. Further evaluation in healthy volunteers, non–small cell lung cancer (NSCLC) patients, and colorectal cancer (CRC) patients was also conducted.
18F-PFPMD was obtained with a high radiochemical yield, radiochemical purity, and stability and was proven to selectively bind to the KRASG12C protein in preclinical studies. The tracer was found to be safe for humans, clearing rapidly from the gallbladder and intestines. In NSCLC and colorectal cancer patients, 18F-PFPMD accumulation was significantly higher in tumors with the KRASG12C mutation as opposed to those without the mutation.
“This research reveals that 18F-PFPMD is a promising molecular imaging tool of significant clinical relevance,” said Wang. “Moving forward, the tracer could be useful to screen the KRASG12C mutation status, as well as for patient selection of KRASG12C targeted therapy. Moreover, it could be used for monitoring therapeutic response and drug resistance for cancer patients.”
This study was made available online in October 2023.
The authors of “First-in-Humans PET Imaging of KRASG12C Mutation Status in Non–Small Cell Lung and Colorectal Cancer Patients Using [18F]PFPMD” include Xiang Li, Jiajun Ye, Jingyi Wang, Zhiyong Quan, Guiyu Li, Wenhui Ma, Mingru Zhang, Weidong Yang, Junling Wang, Taoqi Ma, Fei Kang, and Jing Wang, Department of Nuclear Medicine and State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Xijing Hospital, Fourth Military Medical University, Xi’an, China.
Visit the JNM website for the latest research, and follow our new Twitter and Facebook pages @JournalofNucMed or follow us on LinkedIn.
###
Please visit the SNMMI Media Center for more information about molecular imaging and precision imaging. To schedule an interview with the researchers, please contact Rebecca Maxey at (703) 652-6772 or rmaxey@snmmi.org.
About JNM and the Society of Nuclear Medicine and Molecular Imaging
The Journal of Nuclear Medicine (JNM) is the world’s leading nuclear medicine, molecular imaging and theranostics journal, accessed 15 million times each year by practitioners around the globe, providing them with the information they need to advance this rapidly expanding field. Current and past issues of The Journal of Nuclear Medicine can be found online at http://jnm.snmjournals.org.
JNM is published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. For more information, visit www.snmmi.org.
END
New PET tracer noninvasively identifies cancer gene mutation, allows for more precise diagnosis and therapy
2024-01-02
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Evolution might stop humans from solving climate change, says new study
2024-01-02
Central features of human evolution may stop our species from resolving global environmental problems like climate change, says a new study led by the University of Maine.
Humans have come to dominate the planet with tools and systems to exploit natural resources that were refined over thousands of years through the process of cultural adaptation to the environment. University of Maine evolutionary biologist Tim Waring wanted to know how this process of cultural adaptation to the environment might influence the goal of solving global environmental problems. ...
January issues of APA journals cover antidepressant outcomes, disparities in school-based support, civil commitment hearings, and more
2024-01-02
WASHINGTON, D.C., Jan 2, 2024 — The latest issues of three American Psychiatric Association journals, The American Journal of Psychiatry, Psychiatric Services and The American Journal of Psychotherapy are now available online.
The January issue of The American Journal of Psychiatry features studies focusing on improving clinical outcomes and informing new interventions. Highlights include:
Predicting Acute Changes in Suicidal Ideation and Planning: A Longitudinal Study of Symptom Mediators and the Role of the Menstrual ...
Memory, brain function, and behavior: exploring the intricate connection through fear memories
2024-01-02
In a world grappling with the complexities of mental health conditions like anxiety, depression, and PTSD, new research from Boston University neuroscientist Dr. Steve Ramirez and collaborators offers a unique perspective. The study, recently published in the Journal of Neuroscience, delves into the intricate relationship between fear memories, brain function, and behavioral responses. Dr. Ramirez, along with his co-authors Kaitlyn Dorst, Ryan Senne, Anh Diep, Antje de Boer, Rebecca Suthard, Heloise ...
Demystifying a key receptor in substance use and neuropsychiatric disorders
2024-01-02
New York, NY (January 2, 2024)—Researchers at the Icahn School of Medicine at Mount Sinai have uncovered insights into the potential mechanism of action of the antipsychotic medication asenapine, a possible therapeutic target for substance use and neuropsychiatric disorders. This discovery may pave the way for the development of improved medications targeting the same pathway.
Their findings, detailed in the January 2 online issue of Nature Communications https://doi.org/10.1038/s41467-023-44601-4, show that a brain protein known as the TAAR1 receptor, a drug target known to regulate dopamine signaling in key reward pathways in the brain, differs ...
Elusive cytonemes guide neural development, provide signaling ‘express route’
2024-01-02
St. Jude Children’s Research Hospital scientists found that cytonemes (thin, long, hair-like projections on cells) are important during neural development. Cytonemes connect cells communicating across vast distances but are difficult to capture with microscopy in developing vertebrate tissues. The researchers are the first to find a way to visualize how cytonemes transport signaling molecules during mammalian nervous system development. The findings were published in Cell.
“We showed cytonemes are a direct express route for signal transport,” said corresponding author ...
Pioneering study indicates a potential treatment for corneal endothelial disease, reducing the need for corneal transplants
2024-01-02
Philadelphia, January 2, 2024 – Findings from a pioneering study in The American Journal of Pathology, published by Elsevier, reveal that administration of the neuropeptide α-melanocyte–stimulating hormone (α-MSH) promotes corneal healing and restores normal eye function to an otherwise degenerating and diseased cornea by providing protection against cell death and promoting cell regeneration.
Due to a lack of currently available medical therapy, patients suffering from corneal endothelial disease, ...
Diversity of bioluminescent beetles in Brazilian savanna has declined sharply in 30 years
2024-01-02
At night in the Cerrado, Brazil’s savanna and second-largest biome, larvae of the click beetle Pyrearinus termitilluminans, which live in termite mounds, display green lanterns to capture prey attracted by the bright light.
In more than 30 years of expeditions with his students to Emas National Park and farms around the conservation unit in Goiás state to collect specimens, the phenomenon has never been so rare, said Vadim Viviani, a professor at the Federal University of São Carlos’s Science and Technology for Sustainability Center (CCTS-UFSCar) in Sorocaba, São Paulo state.
“In the 1990s, we ...
Binghamton University professor and Nobel Laureate Stanley Whittingham wins 2023 VinFuture Grand Prize
2024-01-02
Binghamton University, State University of New York Distinguished Professor and Nobel Laureate M. Stanley Whittingham has been chosen as the joint winner of the $3 million 2023 VinFuture Grand Prize in recognition of his contributions to the invention of lithium-ion batteries. The prize recognized how the combination of solar energy and lithium battery storage is overcoming climate change and was recently presented by the Prime Minister of Vietnam.
“I am truly honored to be chosen for this prestigious honor,” said Whittingham. “VinFuture’s efforts to recognize green and sustainable energy is a noble cause, and ...
Deciphering molecular mysteries: new insights into metabolites that control aging and disease
2024-01-02
ITHACA, NY: In a significant advancement in the field of biochemistry, scientists at the Boyce Thompson Institute (BTI) and Cornell University have uncovered new insights into a family of metabolites, acylspermidines, that could change how we understand aging and fight diseases.
The study, recently published in Nature Chemical Biology, presents an unexpected connection between spermidine, a long-known compound present in all living cells, and sirtuins, an enzyme family that regulates many life-essential functions.
Sirtuins ...
Women’s and girls’ sports: more popular than you may think
2024-01-02
COLUMBUS, Ohio – The number of Americans who watch or follow girls’ and women’s sports goes well beyond those who view TV coverage of women’s athletic events, a new study suggests.
In fact, just over half of American adults spent some time watching or following female sports in the past year, the results showed.
U.S. adults spend about one hour a week consuming female sports content, which may seem higher than expected, according to the researchers. Still, it is only a small fraction of Americans’ overall sports consumption.
The study was ...